Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Mannatech, Incorporated    MTEX


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
The feature you requested does not exist. However, we suggest the following feature:

Mannatech Incorporated : Announces Final Results of Tender Offer

share with twitter share with LinkedIn share with facebook
06/30/2020 | 05:16pm EDT

Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced today the final results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of Thursday, June 25, 2020, to purchase up to an aggregate of $5 million in value of its outstanding common stock, par value $0.0001 per share, at a per share price not greater than $17.00 nor less than $15.00 per share (the "tender offer").

Based on the final count by Computershare Trust Company, N.A., the depositary for the tender offer (the "Depositary"), a total of 294,117 shares of common stock of the Company were properly tendered and not properly withdrawn at or below the price of $17.00 per share. Due to the tender offer being oversubscribed, the Company purchased only a prorated portion of those shares properly tendered by each tendering shareholder (other than "odd lot" holders whose shares were purchased on a priority basis) at or below the final per share purchase price. The Company has been informed by the Depositary for the tender offer that the final proration factor for the tender offer was approximately 86%.

In accordance with the terms and conditions of the tender offer, the Company accepted for payment a total of 294,117 shares of common stock of the Company at a cash purchase price of $17.00 per share, for a total cash cost of approximately $5.0 million, excluding fees and expenses relating to the tender offer. Such shares of common stock represented approximately 12.31% of the Company's total outstanding shares as of April 30, 2020. The Depositary will promptly pay for the shares accepted for purchase.

The Company funded the share purchase in the tender offer from cash on hand.

The Company's tender offer was made pursuant to an Offer to Purchase and Letter of Transmittal, each dated May 29, 2020.

About Mannatech

Mannatech, Incorporated is committed to transforming lives through the development of high quality integrated health, weight management, fitness and skin care products distributed through its global network of independent associates and members. The company has been operating for more than 25 years with operations in 25 markets^. For more information, visit Mannatech.com.

^ Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.

Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, the outbreak of the novel coronavirus ("COVID-19") pandemic, Mannatech’s inability to attract and retain associates and preferred customers, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

© Business Wire 2020
share with twitter share with LinkedIn share with facebook
06/30MANNATECH INCORPORATED : Announces Final Results of Tender Offer
06/30MANNATECH INC : Submission of Matters to a Vote of Security Holders, Financial S..
06/29MANNATECH INCORPORATED : Announces Results of Annual Shareholders' Meeting
06/26MANNATECH INCORPORATED : Announces Preliminary Results of Tender Offer
06/11MANNATECH, INCORPORATED : Ex-dividend day for
05/29MANNATECH INCORPORATED : Commences Cash Tender Offer to Purchase up to $5 Millio..
05/28MANNATECH INCORPORATED : Announces Intent to Commence a Cash Tender Offer to Pur..
05/27MANNATECH INCORPORATED : Declares First Quarter 2020 Dividend
05/27MANNATECH INC : Other Events, Financial Statements and Exhibits (form 8-K)
05/12MANNATECH INCORPORATED : Reports First Quarter 2020 Financial Results
More news
Financials (USD)
Sales 2019 158 M - -
Net income 2019 3,29 M - -
Net cash 2019 16,5 M - -
P/E ratio 2019 11,9x
Yield 2019 3,11%
Capitalization 40,7 M 40,7 M -
EV / Sales 2018 0,14x
EV / Sales 2019 0,14x
Nbr of Employees 215
Free-Float 49,8%
Duration : Period :
Mannatech, Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MANNATECH, INCORPORATED
Short TermMid-TermLong Term
Income Statement Evolution
Alfredo Bala President & Chief Executive Officer
J. Stanley Fredrick Chairman
David A. Johnson Chief Financial Officer
Larry A. Jobe Independent Director
Robert A. Toth Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
BY-HEALTH CO., LTD.23.20%4 538
MEDIFAST, INC.36.38%1 761